Thomas Anderson

Thomas D.
Anderson is the founder of Tred Avon Advisors LLC, which was founded in 2018.
He held the title of CEO at Tred Avon Advisors LLC from 2018 to 2021.
Mr. Anderson currently holds multiple positions.
He is the Chief Executive Officer & Director at SwanBio Therapeutics, Inc. since 2019.
He is also an Independent Director at Zevra Therapeutics, Inc. since 2023.
Additionally, he serves as a Partner at Robin Hood Ventures and as a Board Member at ExpressCells, Inc., both since 2019.
In his former positions, Mr. Anderson served as the President & Chief Executive Officer at Andersen Corp.
and Ranir.
He was also the President & CEO at Ranir LLC.
From 2003 to 2004, he worked as an Executive Director at Johnson & Johnson.
He held the position of Executive Director-Market Research at Janssen Pharmaceuticals, Inc. and Senior Vice President-Corporate Strategy at Shire Plc.
He was the Chief Operating Officer & Executive Vice President at Lander Co., Inc. Furthermore, he was a Member of the National Association of Corporate Directors (Philadelphia) from 2019 to 2021.
He served as the Chief Commercial Strategy Officer at SAGE Therapeutics, Inc. from 2014 to 2018.
He was also an Advisory Board Member at Sealink International, Inc. from 2019 to 2021.
Mr. Anderson obtained an MBA from the University of Notre Dame and an undergraduate degree from Lehigh University.